MEMORANDUM OPINION
SLIGHTS, Vice Chancellor.
In the realm of commercial pharmacology, the fight against cancer is as competitive as it is promising. An area of particular promise is the development of so-called PD-1 and PD-L1 inhibitors as anti-cancer therapies. These therapies do not directly attack cancer cells, like traditional chemotherapies...
Let's get started
Welcome to the leading source of independent legal reporting
Sign on now to see your case.
Or view more than 10 million decisions and orders.
- Updated daily.
- Uncompromising quality.
- Complete, Accurate, Current.